La bourse ferme dans 7 h 23 min

Coloplast A/S (COLO-B.CO)

Copenhagen - Copenhagen Cours en temps réel. Devise en DKK
Ajouter à la liste dynamique
854,00+12,80 (+1,52 %)
À partir de 10:07AM CEST. Marché ouvert.

Coloplast A/S

Holtedam 1-3
Humlebæk 3050
Denmark
45 49 11 11 11
https://www.coloplast.com

Secteur(s)Healthcare
Secteur d’activitéMedical Instruments & Supplies
Employés à temps plein15 751

Dirigeants clés

NomTitrePayerExercéAnnée de naissance
Mr. Kristian VillumsenPresident & CEO17,5MS.O.1970
Mr. Anders Lonning-SkovgaardExecutive VP & CFO9MS.O.1972
Mr. Allan RasmussenExecutive Vice President of Global Operations7,9MS.O.1967
Mr. Nicolai Buhl AndersenExecutive Vice President of Innovation7,6MS.O.1969
Mr. Paul MarcunExecutive Vice President of Growth9,1MS.O.1967
Mr. Thomas BarfodSenior Controller & Employees Representative Director450kS.O.1970
Ellen BjurgertVice President of Investor RelationsS.O.S.O.S.O.
Dennis KaysenDirector of Corporate CommunicationsS.O.S.O.S.O.
Dorthe RonnauSenior Vice President of People & CultureS.O.S.O.1966
Mr. Alain MorvanSenior Vice President of Sales EuropeS.O.S.O.S.O.
Les montants ont été établis en date du 31 décembre 2023 et les valeurs de compensation concernent le dernier exercice fiscal clos à cette date. Le terme « rémunération » désigne le salaire, les bonus, etc. Le terme « exercé » est utilisé pour la valeur des options exercées au cours de l’exercice fiscal. Devise exprimée en DKK.

Description

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. The company was founded in 1954 and is headquartered in Humlebæk, Denmark.

Gouvernance d’entreprise

L’ISS Governance QualityScore de Coloplast A/S en date du 1 mai 2024 est 3. Les scores principaux sont Audit : 1; Société : 5; Droits des actionnaires : 9; Compensation : 2.

Résultats de gouvernance d’entreprise offerts par Institutional Shareholder Services (ISS). Les résultats indiquent un rang décile par rapport à l’indice ou à la région. Un résultat décile de 1 indique un risque de gouvernance faible, tandis que 10 indique un risque de gouvernance élevé.